Talk:Lemborexant

Wiki Education Foundation-supported course assignment
This article was the subject of a Wiki Education Foundation-supported course assignment, between 1 September 2021 and 6 December 2021. Further details are available on the course page. Student editor(s): Tardigrade3.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 00:02, 18 January 2022 (UTC)

Structure
The 2-D structure is wrong, it is a dimethyl pyrimidine, not a trim ethyl pyrimidine. The INN Drug list has the correct structure, and the IUPAC name is correct. I'll fix it, if I can get a few minutes today. -217.111.185.11

Significance of faster receptor dissociation
The article says "lemborexant dissociates from the orexin receptors more rapidly than does suvorexant". The reference talks about a dissociation in just 11 minutes. I'm not sure how relevant this is.. and this may be a bit misleading when comparing the possibility of next day effects to other products. The concentration in the blood seems to be what matters! With such a high half life, I would expect that to build up (please correct me if I'm missing something). Danski14(talk) 15:51, 3 August 2023 (UTC)